Analysis-US prices for new drugs fell in 2025 as fewer costly gene therapies were launched
By Deena Beasley
June 25 (Reuters) - Launch prices for prescription medicines approved by U.S. regulators in 2025 fell from the previous year, but remained high at a median of $216,000 due to expensive drugs for rare diseases, a new analysis shows.
In 2024, the median... Read More.


